ANTIBIOTX APS has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals are SHENZHEN NEPTUNUS INTERLONG BI, CIFTER UMIT and AOKI YUKO.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Philippines | 1 | |
#11 | Singapore | 1 | |
#12 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Sommer Morten Otto Alexander | 13 |
#2 | Simon Daniel Jean Jacques | 11 |
#3 | Toft-Kehler Rasmus Vendler | 10 |
#4 | Delavenne Emilie Flora Aurore | 9 |
#5 | Daniel Jean Jacques Simon | 2 |
#6 | Emilie Flora Aurore Delavenne | 2 |
#7 | Rades Thomas | 2 |
#8 | Frandsen Camilla Hasling | 2 |
#9 | Priemel Petra Alexandra | 2 |
#10 | Li Ping | 2 |
Publication | Filing date | Title |
---|---|---|
AU2015314287A1 | Antibacterial use of halogenated salicylanilides |